Weight loss drugs Ozempic and Wegovy would no longer be covered by California’s health insurance for low-income people under ...

Ozempic and Mounjaro, originally diabetes medications, have exploded in popularity as powerful weight-loss injectables.

It’s been nearly two years since the FDA approved their use in kids, but some are questioning if these drugs are safe for ...

BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET. Company Participants. Lucas Montarce - CFO Mike Czapar - SVP, IR. Confe ...

Adult patients taking Wegovy saw a reduced risk of experiencing a major adverse cardiovascular event within the first three months of treatment, according to a secondary analysis of the drug’s ...

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Less than 3% of all people in the U.S. who are eligible for injectable weight loss drugs get a prescription for it, a new ...

Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...

Though Eli Lilly and Novo Nordisk have recently taken steps to make their uber-popular GLP-1 drugs more affordable for ...

The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the ...